Clincosm LogoSign in Get a demo

multidrug resistant tuberculosis

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard

Not yet recruiting
  • Tuberculosis
  • Multidrug Resistant Tuberculosis
  • Tedizolid arm (SIVEXTRO®)
  • +2 more
  • Paris, France
    Bacteriology department- Hôpital Saint-Antoine
Sep 6, 2022

Innovating(IN) Shorter(S), All- Oral, Precised(P),

Not yet recruiting
  • Multidrug Resistant Tuberculosis
  • This is a non-intervention observational study.
  • Guiyang, Guizhou, China
  • +4 more
Oct 5, 2021

Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, Multidrug Resistant Tuberculosis Trial in Bloemfontein (WGS DST

Recruiting
  • Rifampicin Resistant Tuberculosis
  • +3 more
  • WGS DST strategy
  • Bloemfontein, Free State, South Africa
    Free State Department of Health Clinics
Oct 14, 2021

Multidrug Resistant Tuberculosis Trial in Belarus, South Africa, Uzbekistan (Bedaquiline, Pretomanid, Moxifloxacin)

Recruiting
  • Multidrug Resistant Tuberculosis
  • Minsk, Belarus
  • +5 more
May 12, 2021

MDR-TB Close Contacts Tracing in China (TCCT Study)

Not yet recruiting
  • Multidrug Resistant Tuberculosis
    • Shenzhen, Guangzhou, China
    • +7 more
    Jul 20, 2020

    Multidrug Resistant Tuberculosis Trial in China (PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter

    Recruiting
    • Multidrug Resistant Tuberculosis
    • PZA sensitivity guided ultra-short all Oral Regimen
    • Standardized Shorter Regimen
    • Shenzhen, Guangzhou, China
    • +13 more
    Jul 22, 2020

    Multidrug Resistant Tuberculosis Trial in China (WHO-approved MDR-TB regimen, NGS-guided regimen: Regimen A, NGS-guided regimen:

    Not yet recruiting
    • Multidrug Resistant Tuberculosis
    • WHO-approved MDR-TB regimen
    • +3 more
    • Shenzhen, Guangzhou, China
    • +11 more
    Jul 19, 2018

    Multidrug Resistant Tuberculosis, Pediatric Trial in Dasmariñas, Ysterplaat (100 mg Delamanid, 50 mg Delamanid, 25 mg Pediatric

    Completed
    • Multidrug Resistant Tuberculosis
    • Pediatric
    • 100 mg Delamanid
    • +5 more
    • Dasmariñas, Cavite, Philippines
    • +1 more
    Jan 27, 2018

    Pulmonary Tuberculosis, Multidrug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis Trial in Changwon, Seoul

    Completed
    Has Results
    • Pulmonary Tuberculosis
    • +2 more
    • Immediate Start Linezolid
    • Delayed Start Linezolid
    • Changwon, Korea, Republic of
    • +1 more
    Feb 12, 2016

    Simplified Short Regimen for Multidrug Resistant Tuberculosis in

    Unknown status
    • Multidrug Resistant Tuberculosis
    • Short course MDR-TB treatment regimen
    • Nukus, Karakalpakstan, Uzbekistan
      Outpatient clinics in three districts
    Jul 9, 2015

    Multidrug Resistant Tuberculosis Trial in China (Pyrazinamide containing regimen, Regimen without Pyrazinamide)

    Unknown status
    • Multidrug Resistant Tuberculosis
    • Pyrazinamide containing regimen
    • Regimen without Pyrazinamide
    • Chongqing, Chongqing, China
    • +10 more
    Apr 21, 2014